Polymorphisms of HIV-2 integrase and selection of resistance to raltegravir

BACKGROUND: Human Immunodeficiency Virus type 2 is naturally resistant to some antiretroviral drugs, restricting therapeutic options for patients infected with HIV-2. Regimens including integrase inhibitors (INI) seem to be effective, but little data on HIV-2 integrase (IN) polymorphisms and resista...

Descripción completa

Detalles Bibliográficos
Autores principales: Bercoff, Danielle Perez, Triqueneaux, Perrine, Lambert, Christine, Oumar, Aboubacar Alassane, Ternes, Anne-Marie, Dao, Sounkalo, Goubau, Patrick, Schmit, Jean-Claude, Ruelle, Jean
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3006360/
https://www.ncbi.nlm.nih.gov/pubmed/21114823
http://dx.doi.org/10.1186/1742-4690-7-98

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3006360/
https://www.ncbi.nlm.nih.gov/pubmed/21114823
http://dx.doi.org/10.1186/1742-4690-7-98

Ejemplares similares